✦ LIBER ✦

Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group

✍ Scribed by Kaplan, S; Hanauske, AR; Pavlidis, N; Bruntsch, U; te Velde, A; Wanders, J; Heinrich, B; Verweij, J

Book ID: 109837344
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 612 KB
Volume: 73
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1996.70

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel (TaxotereTM) in advanced gastr

Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

Phase II trial of 4′-deoxydoxorubicin (D

Phase II trial of 4′-deoxydoxorubicin (DxDx) in non-small cell lung cancer: A cancer and leukemia group B trial

✍ Ringenberg, Q. Scott ;Perry, Michael C. ;Propert, Kathleen J. ;Modeas, Caron ;Hi 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Single-agent gemcitabine in pretreated p

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial

✍ Kooten, M Van; Traine, G; Cinat, G; Cazap, E; Comba, A Zori; Vicente, H; Sena, S 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB

A phase II trial of oral 4′ demethoxydau

A phase II trial of oral 4′ demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer

✍ P. Presgrave; R. Woods; R. Kefford; D. Bell; D. Raghavan; J. Levi 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 216 KB

4' Demethoxydaunorubicin, an orally active daunorubicin analogue, was administered to 22 patients with inoperable non small cell lung cancer (NSCLC). Patients were stratified into good and poor risk categories and received doses of 45 mg/m 2 and 40 mg/m 2 respectively at 28 day intervals. All 22 pat

Phase II trial of edatrexate plus carbop

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

✍ D. R. Gandara; Martin J. Edelman; John J. Crowley; Derick H. M. Lau; Robert B. L 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 130 KB

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views